Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects

Background: Increased plasma plasminogen activator inhibitor-1 (PAI-1) activity and decreased tissue plasminogen activator (tPA) activity could be considered a true component of the metabolic syndrome (MetS) associated with an increased risk of developing cardiovascular diseases (CVD) and fibrinolyt...

Full description

Saved in:
Bibliographic Details
Main Authors: Al-Hamodi, Z., Ismail, I.S., Saif-Ali, R., Ahmed, K.A., Muniandy, S.
Format: Article
Language:English
Published: 2011
Subjects:
Online Access:http://eprints.um.edu.my/7212/1/Al-Hamodi-2011-Association_of_plasm.pdf
http://eprints.um.edu.my/7212/
http://link.springer.com/article/10.1186%2F1475-2840-10-23?LI=true
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.um.eprints.7212
record_format eprints
spelling my.um.eprints.72122013-12-11T07:16:16Z http://eprints.um.edu.my/7212/ Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects Al-Hamodi, Z. Ismail, I.S. Saif-Ali, R. Ahmed, K.A. Muniandy, S. R Medicine Background: Increased plasma plasminogen activator inhibitor-1 (PAI-1) activity and decreased tissue plasminogen activator (tPA) activity could be considered a true component of the metabolic syndrome (MetS) associated with an increased risk of developing cardiovascular diseases (CVD) and fibrinolytic abnormalities. The aim of this study was to investigate the association of tPA and its inhibitor PAI-1 with type 2 diabetes (T2D) and MetS and interrelationship between PAI-1 and tPA activities and antigens in Malaysian T2D and normal subjects. Methods: The plasma activities and antigens of PAI-1 and tPA and the levels of the tPA/PAI-1 complex as well as serum insulin, parameter of the coronary risk panel and plasma glucose at fasting state were studied in 303 T2D subjects (227 with MetS and 76 without MetS), 131 normal non-diabetic non-metabolic subjects and 101 nondiabetic MetS subjects. Results: The PAI-1 activity was higher in subjects with T2D with MetS (P = 9.8 x 10(-19)) and non-diabetic subjects with MetS (P = 3.0 x 10(-15)), whereas the tPA activity was lower in T2D with MetS (P = 0.003) as compare to normal subjects. Plasma tPA antigen levels were higher in subjects with T2D with MetS (P = 8.9 x 10(-24)), T2D without MetS (P = 1.3 x 10(-13)) and non-diabetic MetS subjects (P = 0.002). The activity and antigen of PAI-1 in normal subjects were related to insulin resistance (P = 2.2 x 10(-4); 0.007). Additionally, the PAI-1 activity was associated with an increased waist circumference (P = 2.2 x 10(-4)) and decreased HDL-c (P = 0.005), whereas the tPA activity was associated with decreased FBG (P = 0.028). The highest correlation was between PAI-1 activity and its antigen (R(2) = 0.695, P = 1.1 x 10(-36)) in diabetic subjects. The tPA activity negatively correlated with its antigen (R(2) = -0.444, P = 7.7 x 10(-13)) in normal subjects and with the PAI-1 activity and antigen (R(2) = -0.319, P = 9.9 x 10(-12); R2 = -0.228, P = 3.4 x 10(-6)) in diabetic subjects. Conclusions: PAI-1 and tPA activities and antigens were associated with diabetes and MetS parameters in Malaysian subjects. 2011 Article PeerReviewed application/pdf en http://eprints.um.edu.my/7212/1/Al-Hamodi-2011-Association_of_plasm.pdf Al-Hamodi, Z. and Ismail, I.S. and Saif-Ali, R. and Ahmed, K.A. and Muniandy, S. (2011) Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects. Cardiovascular Diabetology, 10. ISSN 1475-2840 http://link.springer.com/article/10.1186%2F1475-2840-10-23?LI=true 10.1186/1475-2840-10-23
institution Universiti Malaya
building UM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Malaya
content_source UM Research Repository
url_provider http://eprints.um.edu.my/
language English
topic R Medicine
spellingShingle R Medicine
Al-Hamodi, Z.
Ismail, I.S.
Saif-Ali, R.
Ahmed, K.A.
Muniandy, S.
Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
description Background: Increased plasma plasminogen activator inhibitor-1 (PAI-1) activity and decreased tissue plasminogen activator (tPA) activity could be considered a true component of the metabolic syndrome (MetS) associated with an increased risk of developing cardiovascular diseases (CVD) and fibrinolytic abnormalities. The aim of this study was to investigate the association of tPA and its inhibitor PAI-1 with type 2 diabetes (T2D) and MetS and interrelationship between PAI-1 and tPA activities and antigens in Malaysian T2D and normal subjects. Methods: The plasma activities and antigens of PAI-1 and tPA and the levels of the tPA/PAI-1 complex as well as serum insulin, parameter of the coronary risk panel and plasma glucose at fasting state were studied in 303 T2D subjects (227 with MetS and 76 without MetS), 131 normal non-diabetic non-metabolic subjects and 101 nondiabetic MetS subjects. Results: The PAI-1 activity was higher in subjects with T2D with MetS (P = 9.8 x 10(-19)) and non-diabetic subjects with MetS (P = 3.0 x 10(-15)), whereas the tPA activity was lower in T2D with MetS (P = 0.003) as compare to normal subjects. Plasma tPA antigen levels were higher in subjects with T2D with MetS (P = 8.9 x 10(-24)), T2D without MetS (P = 1.3 x 10(-13)) and non-diabetic MetS subjects (P = 0.002). The activity and antigen of PAI-1 in normal subjects were related to insulin resistance (P = 2.2 x 10(-4); 0.007). Additionally, the PAI-1 activity was associated with an increased waist circumference (P = 2.2 x 10(-4)) and decreased HDL-c (P = 0.005), whereas the tPA activity was associated with decreased FBG (P = 0.028). The highest correlation was between PAI-1 activity and its antigen (R(2) = 0.695, P = 1.1 x 10(-36)) in diabetic subjects. The tPA activity negatively correlated with its antigen (R(2) = -0.444, P = 7.7 x 10(-13)) in normal subjects and with the PAI-1 activity and antigen (R(2) = -0.319, P = 9.9 x 10(-12); R2 = -0.228, P = 3.4 x 10(-6)) in diabetic subjects. Conclusions: PAI-1 and tPA activities and antigens were associated with diabetes and MetS parameters in Malaysian subjects.
format Article
author Al-Hamodi, Z.
Ismail, I.S.
Saif-Ali, R.
Ahmed, K.A.
Muniandy, S.
author_facet Al-Hamodi, Z.
Ismail, I.S.
Saif-Ali, R.
Ahmed, K.A.
Muniandy, S.
author_sort Al-Hamodi, Z.
title Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
title_short Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
title_full Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
title_fullStr Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
title_full_unstemmed Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
title_sort association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in malaysian subjects
publishDate 2011
url http://eprints.um.edu.my/7212/1/Al-Hamodi-2011-Association_of_plasm.pdf
http://eprints.um.edu.my/7212/
http://link.springer.com/article/10.1186%2F1475-2840-10-23?LI=true
_version_ 1643687990925459456
score 13.214268